FDA Clears Greystone Medical Group's Epi-Max for Sale in the U.S. MEMPHIS, Tenn., May 19, 2005 (PRIMEZONE) -- Greystone Medical Group announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market and sell Epi-Max(r), a wound care...

FDA Clears Greystone Medical Group's Epi-Max for Sale in the U.S. MEMPHIS, Tenn., May 18, 2005 (PRIMEZONE) -- Greystone Medical Group announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market and sell Epi-Max(r), a wound care...

U.S. DOD Funds Research on Hemorrhage-Stopping Drug MEMPHIS, Tenn., Feb. 24, 2005 (PRIMEZONE) -- The U.S. Defense Department has awarded $750,000 to Greystone Medical Group and the University of Tennessee Health Science Center (UTHSC) to complete...